Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11447745 End-to-end cell therapy automation

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

September 20, 2022

0

Patent Application Number

161196180

Date Filed

August 31, 2018

0

Patent Citations

US Patent 11208626 Cell culture device, system and methods of use thereof

0

Patent Citations Received

US Patent 11701654 Fluid connector

0

US Patent 11781113 End-to-end cell therapy automation

US Patent 11786896 Fluid connector

US Patent 11827902 End-to-end cell therapy automation

0

US Patent 11872557 Apparatus and method for control of cell processing system

0

Patent Primary Examiner

0

The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11447745 End-to-end cell therapy automation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool